You just read:

Public Offerings, Merger Agreements, New Preclinical Data, New Treatments and Dividend Payments - Research Report on XOMA, MAKO, Alnylam, Avanir, and PDL BioPharma

News provided by

Analysts' Corner

Dec 18, 2013, 08:00 ET